Awards

Lead411 Technology 500frost-sullivan-innovatePharma Voice 100INC 5000 HonoreeMobil Village Star Awardao100 WinnerSociety for Clinical Data ManagementBio-IT World ChampionsRed Herring 100 WinnerConsumer Value Enhancement AwardLifeScience Insights

2013 SCDM Data Driven Innovation Award

The Society for Clinical Data Management presented their Data Driven Innovation Award to Nextrials for its EHR integration tool, E2E. SCDM initiated this award in 2007 to recognize innovative technology solutions in clinical trial data management. Nextrials has been working on the EHR integration standards with CDISC and IHE for over 5 years and has added a number of operational enhancements to its tool to accommodate work processes seen with clinical trials. In 2013, Nextrials initiated the first implementation of these standards on a multi-site prospective clinical trial using multiple EHR vendors.

2010 Lead411 Technology 500

Nextrials has been selected as one of the top 500 technology companies in the U.S. by Lead411. This is the first time Nextrials has appeared on the annual list of privately held technology companies with over $1M in revenue. Based on its percentage of revenue growth from 2007-2009, Nextrials achieved the ranking of No. 491.

2010 Inc. 5000

Nextrials has been selected for the fourth consecutive year for the prestigious Inc. 5000, an exclusive list of the fastest growing private companies in the U.S. Despite the challenging financial economics within the pharmaceutical industry in 2009, Nextrials maintained its position on the Inc. 5000 and achieved the national ranking of No. 2,678, based on the company’s year over year revenue growth for the past three years.

2009 Inc. 5000

Nextrials again earned a spot on the 2009 prestigious Inc. 5000, an exclusive list of the fastest growing private companies in the U.S.  Nextrials grew 110.2 percent in 2008 and achieved the national ranking of No. 2,667, making it one of the top 20 healthcare-related companies in California. This is the third consecutive year that Nextrials has been selected for the Inc. 5000, based on the company’s year over year revenue growth for the past three years.

again
earned a spot on this year’s prestigious Inc. 5000, an exclusive list of the fastest growing
private companies in the U.S.  Nextrials grew 110.2 percent in 2008 and achieved the
national ranking of No. 2,667, making it one of the top 20 healthcare-related companies
in California. This is the third consecutive year that Nextrials has been selected for the
Inc. 5000, based on the company’s year over year revenue growth for the past three
years.

2009 Pharma Voice 100 (Lecia Shaffer)

Nextrials’ co-founder and vice president of operations and clinical services Lecia Shaffer was named to the 2009 PharmaVOICE 100 list in recognition of her influence as a leader in research and clinical trial data management. The PharmaVOICE 100 annually showcases the people who are providing inspiration, motivation and positive influence in corporate leadership, research and development, technology, creativity, marketing and business strategies within the life sciences industry.

2009 Frost & Sullivan’s Clinical Trials Management Product Innovation of the Year Award

Frost & Sullivan recognized Nextrials’ flagship electronic data capture (EDC) and clinical trial management platform, Prism®, for its ability to integrate with electronic health records (EHR) systems, thereby improving patient data exchange between the clinical trial and the healthcare setting.

2008 Gold Mobile Star Award

Nextrials’ flagship electronic data capture and clinical trial management software, Prism®, captured a 2008 Gold Mobile Star Award from MobileVillage, the 15-year leader in market development and news services about mobile technology. Prism® was a winner in the enterprise software category for healthcare data capture. Most notably for Prism®’s recently added support for remote access via the Apple iPhone, giving researchers anywhere/anytime access to ongoing clinical trial data.

2008 Inc. 5000

Nextrials improved its ranking on the 2008 Inc. 5000 list of the fastest-growing private companies in America, coming in at No. 2,364 with a 155 percent sales growth over the last three years.  This growth rate beats the national average for private companies and places Nextrials in the top 100 businesses in the San Francisco-Oakland-Fremont, California area. The 5000 companies that made the list reported aggregate revenue of $185 billion and median three-year growth of 147 percent.

2008 Product Innovation Award

Nextrials was honored by the Silicon Valley Communications’ Network Products Guide selection of Prism®, the company’s clinical trial management platform, for a 2008 Product Innovation Award in the Software-as-a-Service category.  This annual competition recognizes vendors with groundbreaking products that set the bar higher for others in all areas of information technology.

2007 Always On 100 Top Private Company Award

Nextrials was chosen by AlwaysOn as one of the AO100 Top Private Companies for 2007. The fifth-annual elite AO100 list was compiled by the AlwaysOn editorial panel. In order to be eligible for the AO100 list, companies had to be peer-nominated, with AlwaysOn receiving more than 1,000 nominations from venture investors, investment bankers and other industry experts. Nextrials was honored for its work in developing new and innovative Internet-based technology solutions for the pharmaceutical and biotechnology industries.

2007 BioIT World Champion 2.0

Nextrials was one of 50 featured technology companies designated as Champions 2.0 in the March 2007 issue of Bio-IT World magazine. The title, “Champions 2.0,” refers to the companies’ abilities to overcome market challenges and achieve milestones in the pharmaceutical and biotechnology industries during the last five years.

2007 Inc. 5000

Nextrials was honored on the 2007 Inc. 5000 list of fastest-growing private companies in America. To qualify, companies had to be U.S.-based and privately held, independent – not subsidiaries or divisions of other companies – as of December 31, 2006, and have had at least $200,000 in revenue in 2003, and $2 million in 2006.

2007 Pharma Voice 100 (Jim Rogers)

Nextrials’ co-founder, president and CEO James H. Rogers was named to the 2007 PharmaVOICE 100 list in recognition of his long career of innovative contributions to the pharmaceutical and biotechnology industries. The PharmaVOICE 100 list annually showcases the greatest influencers impacting corporate leadership, research and development, technology, creativity, marketing and business strategies within the life sciences.

2007 SCDM Data Driven Innovation Awards

Nextrials and its partner Z-Tech (Canada) Inc. were selected as the runner-up winner in the 2007 Society of Clinical Data Management’s Data Driven Innovation Award competition. The companies jointly developed an integrated methodology for directly capturing clinical trial data collected by Z-Tech’s Azura BreastScan™ breast cancer detection system and subsequently delivering that data to be stored in Nextrials’ Prism® clinical trial management platform.

2006 Red Herring Top 100

Nextrials was presented with the 2006 Red Herring 100 North America Award. Over 1,000 privately held technology companies were considered for this prestigious award that recognizes new and innovative technology firms and their entrepreneurial founders. Nextrials was rigidly evaluated on quantitative and qualitative criteria such as financial performance, technology innovation, quality of management, execution of strategy and integration into their ecosystem.

2006 Bio-IT 50

Nextrials was named to Bio-IT World’s Bio-IT 50, a list of the top life sciences firms that, in the opinion of the editors, provide the most indispensable, enabling technologies for pharmaceutical and biotechnology organizations. In selecting Nextrials for the list, editors noted that the company “has an unusually full-featured EDC application that works across multiple phases of trials.” Calling the company “small but powerful,” the editors also highlighted the fact that Nextrials is pioneering the electronic transfer of laboratory data in accordance with the Clinical Data Interchange Standards Consortium (CDISC) standards.

2004 BioIT World Best of Show

Nextrials’ innovation and technical merit were recognized in March 2004 at the Bio-IT World Expo with a “Best of Show” award in clinical trials and research. Prism®’s drug and device inventory management system was named the “Most Innovative Product,” superior to Oracle Corporation’s EDC software and PHT Corp’s handheld diary device.

2004 Frost and Sullivan Customer Value Enhancement Award

Nextrials also received the 2004 “Customer Value Enhancement Award” in the electronic trials market by Frost & Sullivan. The award acknowledges Nextrials’ success at establishing long-term relationships with its customers and keeping pace with evolving end-user demands by constantly incorporating customer feedback into each product enhancement.

2004 Life Science Insights (Top Four Industry Leaders)

Nextrials was recognized by Life Science Insights, an IDC Company, as one of the top four industry leaders in 2004. The ranking was based on a profiling of vendors’ competitive positioning within the U.S. clinical trial management systems market. Nextrials was placed in the leadership portion of the grid on the basis of the strength of its extensive product offering and an estimate of the company’s potential to build additional market share as the market grows.

Top